Insider · CIK 0001381450
Jeffrey Alan Wolf
Files at TOVX (Theriva Biologics, Inc.). First filing -, latest -.
In brief
Jeffrey Alan Wolf files SEC Form 4 as director at TOVX (Theriva Biologics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeffrey Alan Wolf has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | TOVX Theriva Biologics, Inc. | AGrant or award Stock Options (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jan 6, 2026 |
| Apr 29, 2025 | TOVX Theriva Biologics, Inc. | AGrant or award Stock Options (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | May 1, 2025 |
Questions about Jeffrey Alan Wolf
Answered from the filings on this page, as of the latest one.
Is Jeffrey Alan Wolf buying or selling?
Jeffrey Alan Wolf has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeffrey Alan Wolf's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey Alan Wolf has 0.
Where does Jeffrey Alan Wolf file Form 4?
Jeffrey Alan Wolf has filed Form 4 at TOVX (Theriva Biologics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.